News
Novartis AG recalls 4 over-the-counter drugs
Novartis AG said Sunday it is voluntarily recalling some over-the-counter products in the U.S., including its Excedrin headache pills and NoDoz medication, because they...
News
US FDA grants orphan drug status to CanBas’ CBP501...
CanBas Co, a clinical-stage biopharmaceutical company, has received orphan drug designation fro the United States Food and Drug Administration (FDA) for it's CBP501 "for...
News
Acella Pharma acquires Prenate family of trademarks and associated...
Acella Pharmaceuticals, LLC, a company that develops, markets, sells and distributes a broad portfolio of non-branded pharmaceutical and other products, acquires a leading US...
News
Lilly Recognized as One of the Best Places to...
For the sixth consecutive year, Eli Lilly and Company has received a 100 percent rating on the Human Rights Campaign (HRC) Corporate Equality Index...
News
EMA recognizes Takeda’s pioglitazone-containing medicines remain a valid treatment...
Takeda Pharmaceutical Company Limited announced that at the request of the European Commission (EC), the European Medicines Agency (EMA)’s Committee for Medical Products for Human...
News
BYETTA Approved for Use with Insulin Glargine in the...
Amylin Pharmaceuticals, Inc., and Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has approved a new use for BYETTA®...
News
Vertex Submits Application for Priority Review and Approval of...
Vertex Pharmaceuticals Incorporated announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for KALYDECO™ (VX-770, ivacaftor),...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.